[{"address1": "Ole MaalOees Vej 3", "address2": "Copenhagen N", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.iobiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGF\u00df1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.", "fullTimeEmployees": 80, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mai-Britt  Zocca Ph.D.", "age": 56, "title": "Founder, President, CEO, Principal Financial Officer & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 908461, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Qasim Iftikhar Ahmad M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 709800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Inge Marie Svane M.D., Ph.D.", "title": "Founder & Clinical Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Mads Hald Andersen M.D., Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anders  Ljungqvist", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Per Thor Straten", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel G. Mannix Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Faical  Miyara Ph.D.", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Marjan  Shamsaei Pharm.D.", "title": "Senior VP of Commercial Development & Portfolio Lead", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.01, "open": 1.06, "dayLow": 0.96, "dayHigh": 1.06, "regularMarketPreviousClose": 1.01, "regularMarketOpen": 1.06, "regularMarketDayLow": 0.96, "regularMarketDayHigh": 1.06, "payoutRatio": 0.0, "beta": 0.083, "forwardPE": -0.8717949, "volume": 54191, "regularMarketVolume": 54191, "averageVolume": 156006, "averageVolume10days": 81230, "averageDailyVolume10Day": 81230, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 67198520, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 1.79, "fiftyDayAverage": 0.95682, "twoHundredDayAverage": 1.043705, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9082532, "profitMargins": 0.0, "floatShares": 31415973, "sharesOutstanding": 65880900, "sharesShort": 112344, "sharesShortPriorMonth": 50028, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0017, "heldPercentInsiders": 0.0033500001, "heldPercentInstitutions": 0.67359, "shortRatio": 0.45, "shortPercentOfFloat": 0.0047, "impliedSharesOutstanding": 65880900, "bookValue": 0.714, "priceToBook": 1.4285715, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -95491000, "trailingEps": -1.45, "forwardEps": -1.17, "enterpriseToEbitda": -0.096, "52WeekChange": -0.31543624, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 1.02, "targetHighPrice": 12.0, "targetLowPrice": 6.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 60031000, "totalCashPerShare": 0.911, "ebitda": -94924000, "totalDebt": 1915000, "quickRatio": 3.139, "currentRatio": 3.333, "debtToEquity": 4.073, "returnOnAssets": -0.5447, "returnOnEquity": -1.05997, "freeCashflow": -49305624, "operatingCashflow": -82347000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IOBT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "IO Biotech, Inc.", "longName": "IO Biotech, Inc.", "regularMarketPrice": 1.02, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1746216308, "regularMarketTime": 1746216001, "exchange": "NMS", "messageBoardId": "finmb_1685354464", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -1.45, "epsForward": -1.17, "epsCurrentYear": -1.17333, "priceEpsCurrentYear": -0.8693207, "fiftyDayAverageChange": 0.06317997, "fiftyDayAverageChangePercent": 0.066031195, "twoHundredDayAverageChange": -0.023705006, "twoHundredDayAverageChangePercent": -0.022712363, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-05", "postMarketChangePercent": 0.0, "postMarketPrice": 1.02, "postMarketChange": 0.0, "regularMarketChange": 0.00999999, "regularMarketDayRange": "0.96 - 1.06", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 156006, "fiftyTwoWeekLowChange": 0.35999995, "fiftyTwoWeekLowChangePercent": 0.54545444, "fiftyTwoWeekRange": "0.66 - 1.79", "fiftyTwoWeekHighChange": -0.77, "fiftyTwoWeekHighChangePercent": -0.4301676, "fiftyTwoWeekChangePercent": -31.543625, "regularMarketChangePercent": 0.99009806, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636119000000, "displayName": "IO Biotech", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]